Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Director and Officer

On December 9, 2022, Mr. Daniel Johnson tendered his resignation as the Chief Financial Officer and as a director of ABG Acquisition Corp. I (the "Company"), effective December 9, 2022. The resignation of Mr. Johnson was not a result of any disagreement with the Company's operations, policies or procedures.

Appointment of Director and Officer

Effective December 14, 2022, the board of directors of the Company has appointed Kevin C. Reilly as a director of the Company and as Chief Financial Officer, filling the vacancy left by Mr. Johnson.

Mr. Reilly, age 32, joined Ally Bridge Group in 2021 and is currently a managing director focused on private equity strategies in healthcare market sectors. Before joining Ally Bridge Group, Mr. Reilly was a principal focused on medical technology investments at CRG, L.P., a healthcare investment management firm providing growth capital to companies through the form of long-term debt and equity, beginning in 2014. Mr. Reilly began his career in 2012 in the Healthcare Investment Banking Group at Stifel, Nicolaus & Company, Inc. Mr. Reilly holds a Bachelor of Science degree in Finance and Information Systems from the University of Maryland.

In connection with Mr. Reilly's appointment as Chief Financial Officer and a director of the Company, the Company entered into the following agreements:



     •    A Letter Agreement, as of December 14, 2022 (the "Letter Agreement"),
          between the Company and Mr. Reilly, pursuant to which Mr. Reilly agreed
          to: vote any ordinary shares of the Company held by him in favor of the
          Company's initial business combination; facilitate the liquidation and
          winding up of the Company if an initial business combination is not
          consummated within the time period required by its amended and restated
          memorandum and articles of association; and certain transfer restrictions
          with respect to the Company's securities.



     •    An Indemnity Agreement, as of December 14, 2022 (the "Indemnity
          Agreement"), between the Company and Mr. Reilly, providing Mr. Reilly
          certain contractual indemnification in addition to the indemnification
          provided for in the Company's amended and restated memorandum and
          articles of association.

Mr. Reilly is not expected to enter into an employment agreement or receive any compensation from the Company for serving as the Company's Chief Financial Officer and as a director. Mr. Reilly is not expected to be appointed to any committees of the Company's board of directors.

--------------------------------------------------------------------------------

Other than as disclosed above, there are no arrangements or understandings between Mr. Reilly and any other persons pursuant to which Mr. Reilly was selected as a director and an executive officer of the Company. There are no family relationships between Mr. Reilly and any of the Company's other directors or executive officers and Mr. Reilly does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses